Grifols, S.A. (ADR) (GRFS) — closed signal from September 29, 2025
Partial Published before the outcome was known, scored automatically when the window closed on December 28, 2025.
Predicted vs. what happened
What happened
Reached 16% of the predicted growth at its peak, without hitting the target.
The thesis — published September 29, 2025
Shares look beaten down, and short-term price signs suggest they may rebound in a controlled way. A known ratings service gives it a solid mark (Rank 2). The stock also looks reasonably priced versus its assets and cash generation. The company plans to roughly double its medicine processing capacity in Europe, which could support growth over the next year. Over about 3 months, the market may revalue it, but keep risk small.
Primary drivers
- Stock looks sold off, with early signs the short-term trend is improving
- Valuation looks reasonable, and a well-known rater scores it at Rank 2
- Plan to nearly double European processing capacity could lift sales
- Short-term mood around the stock is improving, aiding a bounce
How it played out
GRFS: target was never reached
Lyra published GRFS at 9.95 on 2025-09-29 with an 18% expected gain over a short-term window. The thesis pointed to a sold-off stock with early signs of a better short-term trend, a reasonable valuation, a Rank 2 score from a known ratings service, a plan to nearly double European medicine processing capacity, and improving short-term mood around the stock.
Inside the window, GRFS peaked at 10.23 on 2025-10-02, a 2.8% gain. It stayed below the 11.74 target and never reached it. The stock ended at 9.10 on 2025-12-28. The thesis missed.
What happened during the window
On 2025-11-04, Cinco Días reported that Grifols posted third-quarter revenue of 1.865 million euros and nine-month revenue of 5.542 million euros. On 2025-11-27, Cinco Días reported that Grifols named Tomás Dagá vice president of the board of Grifols Egypt for Plasma Derivatives.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.